Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Helen Walker
Observed names:
Helen E Walker,
Walker Helen
Institution:
Mundipharma (United Kingdom)
Observed institutions:
Genentech,
Mundipharma (United Kingdom),
Quotient Clinical (United Kingdom),
Quotient Sciences Limited (United Kingdom)
ORCID:
0009-0008-1891-2012
Observed ORCID:
0009-0008-1891-2012
OpenAlex ID:
A5027988414
Population pharmacokinetic modeling and target attainment analyses of rezafungin for the treatment of candidemia and invasive candidiasis
2023
·
Stefan Roepcke
, Julie Passarell
, et al.
·
Antimicrobial Agents and Chemotherapy
·
28
Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations
2023
·
Shawn Flanagan
, Helen Walker
, et al.
·
Microbiology Spectrum
·
27
Absence of Pharmacokinetic Interactions between the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate
2019
·
Nicholas Steven Jones
, Helen Winter
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
6
PDF
Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects
2018
·
Sravanthi Cheeti
, Hao Helen Hou
, et al.
·
Pharmaceutical Research
·
6
PDF
Absorption, metabolism and excretion of [14C]-gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans
2017
·
Sung-Hack Lee
, Namtae Kim
, et al.
·
Drug Metabolism and Pharmacokinetics
·
3
A phase I, open-label, 2-part study to establish absolute bioavailability and the absorption, metabolism and excretion of evogliptin in healthy male subjects by a light-label approach
2017
·
Ji Su Song
, Dae Young Lee
, et al.
·
Drug Metabolism and Pharmacokinetics
·
3
1694. Coadministration of Rezafungin Does Not Impact the Pharmacokinetics of Cyclosporine, Ibrutinib, Mycophenolate Mofetil, or Venetoclax
2022
·
Shawn Flanagan
, Helen E Walker
, et al.
·
Open Forum Infectious Diseases
·
2
P47 - An integrated radiolabelled study to determine the absorption, metabolism, excretion and absolute bioavailability of pemafibrate in healthy male subjects
2020
·
Iain Shaw
, Neil Hounslow
, et al.
·
Drug Metabolism and Pharmacokinetics
P46 - Understanding the excretion profile and the metabolism of pitolisant in CYP450 2D6 poor and extensive metabolisers at steady state
2020
·
Iain Shaw
, Philippe Robert
, et al.
·
Drug Metabolism and Pharmacokinetics
P47-健康な男性被験者におけるペマフィブレートの吸収,代謝,排泄および絶対バイオアベイラビリティを決定するための統合放射性標識研究
2020
·
Shaw Iain
, Hounslow Neil
, et al.
Application of non-standard approaches to investigations of human mass balance and metabolite characterisation
2019
·
Iain Shaw
, Walker Helen
, et al.
·
Drug Metabolism and Pharmacokinetics
Show more works
View as search
Works count:
11
Citation count:
75
H-index:
4
I10-index:
2
Year
Topic
Type